SSBP2 and metastatic carcinoma: Overall, a loss of nuclear SSBP2 expression was observed in 134 (34.3%) primary colorectal adenocarcinoma and 100 (76.3%) metastatic carcinoma tissues, while all normal colonic mucosa and adenoma tissues showed a positive SSBP2 expression.